Nuveen Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,701,137
| Closed | -$10.6M | – | 3526 |
|
|
2022
Q1 | $10.6M | Buy |
2,701,137
+14,584
| +0.5% | +$57.3K | ﹤0.01% | 1599 |
|
|
2021
Q4 | $9.59M | Sell |
2,686,553
-66,987
| -2% | -$239K | ﹤0.01% | 1721 |
|
|
2021
Q3 | $10M | Buy |
2,753,540
+216,874
| +9% | +$789K | ﹤0.01% | 1782 |
|
|
2021
Q2 | $11.1M | Buy |
2,536,666
+148,682
| +6% | +$648K | ﹤0.01% | 1808 |
|
|
2021
Q1 | $9.81M | Buy |
2,387,984
+1,174,117
| +97% | +$4.83M | ﹤0.01% | 1813 |
|
|
2020
Q4 | $4.84M | Buy |
1,213,867
+78,767
| +7% | +$314K | ﹤0.01% | 2095 |
|
|
2020
Q3 | $3.07M | Sell |
1,135,100
-17,965
| -2% | -$48.5K | ﹤0.01% | 2174 |
|
|
2020
Q2 | $3.17M | Buy |
1,153,065
+21,616
| +2% | +$59.4K | ﹤0.01% | 2129 |
|
|
2020
Q1 | $2.67M | Buy |
1,131,449
+18,181
| +2% | +$42.9K | ﹤0.01% | 2045 |
|
|
2019
Q4 | $5.23M | Buy |
1,113,268
+367,856
| +49% | +$1.73M | ﹤0.01% | 1973 |
|
|
2019
Q3 | $2.49M | Buy |
745,412
+60,975
| +9% | +$204K | ﹤0.01% | 2305 |
|
|
2019
Q2 | $2.25M | Buy |
+684,437
| New | +$2.25M | ﹤0.01% | 2379 |
|
|
2016
Q2 | – | Sell |
-10,488
| Closed | -$9 | – | 1393 |
|
|
2016
Q1 | $9 | Buy |
+10,488
| New | +$9 | ﹤0.01% | 1356 |
|